19:10 - 21:00
Room: Ishikawa Ongakudō Interchange Hall
Poster Session
Pulmonary administration of Duox2 DNA induces interferon secretion in vivo lung against acute influenza A viral infection
Hyun Jik Kim, Yung Jin Jeon, Ara Jo, Sujin An
Seoul National University College of Medicine, Seoul, Korea, Republic of (South)

Background We studied the contribution of Duox2 in mucosal host defense against influenza A virus (IAV) infection in vivo lung. We found that Duox2 was required for the induction of type I and III interferon (IFN)s and transient Duox2 overexpression lead to suppress IAV infection in vivo lung.

Methods 20 Mice (C57BL/6J) were anesthetized and challenged by intranasal administration of 213 pfu/30 ul of IAV (WS/33/H1N1) and IAV-infected mice were euthanized at 1, 3, 5, 7, 10, 14 days post of infection (dpi). Duox2 shRNA and pCMV-Duox2 were inoculated to mice to assess the regulatory mechanism between Duox2 and IFN secretion.

Results Following intranasal IAV inoculation, viral infection was significantly aggravated from 3 dpi in vivo lung and viral titer was highest at 7 dpi. Consistent with this, Duox2 mRNA and protein expressions were significantly induced from 3 dpi in the lung tissue of IAV-infected mice. Viral titer was much higher in IAV-infected mice that were inoculated with Duox2 shRNA accompanied with lower survival rate and extensive lung pathologies. Interestingly, severe lung pathologies in IAV-infected mice were not observed and viral titer was significantly reduced in mice with pulmonary administration of pCMV-Duox2 before IAV inoculation. Both mRNA and secreted protein levels of IFN-β and IFN-λ2/3 were highly elevated in IAV-infected mice with pCMV-Duox2.

Conclusion Duox2 is necessary for the regulation of IFNs secretion in vivo lung and pulmonary administration of Duox2 DNA trigger the induction of type I and III IFNs resulting in more complete suppression of IAV infection.


Reference:
Tu-P6-6
Session:
Poster Session 6 “Cytokines in mucosal immunity”
Presenter/s:
Hyun Jik Kim
Presentation type:
Poster Presentation
Room:
Ishikawa Ongakudō Interchange Hall
Date:
Tuesday, 31 October 2017
Time:
19:10 - 21:00
Session times:
19:10 - 21:00